About Waters Corp
- Industry: Life Sciences Tools & Services
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.waters.com
Frequently Asked Questions
What is the 52-week range for WAT?
The 52-week high is $448.21 and the 52-week low is $282.77.
What is the P/E ratio for WAT?
The Price to Earnings (P/E) ratio is 258.23.
What is the dividend yield for WAT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 1.88%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 3.58%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 8.83.
Analyst Recommendation Trends
Wall Street analyst consensus for WAT over the last few months:
Latest WAT News
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call
Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least December 1, 2026, at midnight Eastern Time.
Guggenheim Maintains Buy on Waters, Raises Price Target to $490
Guggenheim analyst Subbu Nambi maintains Waters (NYSE:WAT) with a Buy and raises the price target from $440 to $490.
If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today
Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 11.99%. Currently, Waters has a market capitalization of $43.33 billion. Buying
1 Volatile Stock with Promising Prospects and 2 We Avoid
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.
The Bull Case For Waters (WAT) Could Change Following New At-Home HPV And Cell Analysis Push
In mid-September 2026, Everlywell announced a partnership with Waters Corporation to support at-home HPV cervical cancer screening, while Waters also launched the BD FACSDiscover A7 Cell Analyzer globally, expanding access to advanced flow cytometry for research labs. Together, these moves highlight Waters’ growing role in connected diagnostics and high-parameter cell analysis, deepening its presence across clinical and research workflows. Next, we’ll examine how the expanded at-home HPV...
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum
Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses. Speaking at a JPMo
1 Growth Stock with All-Star Potential and 2 We Find Risky
Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Waters: Positive Momentum Rides High Again
Waters has rebounded sharply, with shares rising from $300 to $425 on solid organic and acquired sales growth. Click to read more about the WAT stock here.
Robust Results Lifted Waters (WAT)
Madison Investments, an investment advisor, released its second-quarter 2026 investor letter for the “Madison Mid Cap Fund”. You can download a copy of the letter here. U.S. stock market indices posted their strongest second-quarter performance since 2020, driven largely by enthusiasm for Artificial Intelligence. Nine of the ten largest companies in the Russell Midcap Index […]
Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
Waters Corporation (WAT) U.S. All Stars Conference September 23, 2026 7:00 AM EDTCompany ParticipantsUdit Batra - President, CEO & DirectorConference...
Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.
Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515
Goldman Sachs analyst Evie Koslosky maintains Waters (NYSE:WAT) with a Buy and raises the price target from $465 to $515.
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry
WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
How Is Waters Corporation's Stock Performance Compared to Other Health Care Stocks?
Waters Corporation has outperformed the Health Care industry over the past year, and analysts are moderately optimistic about the stock’s prospects.
3 Large-Cap Stocks for Long-Term Investors
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
2 Cash-Producing Stocks to Consider Right Now and 1 We Question
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 S&P 500 Stock Worth Your Attention and 2 We Avoid
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectral resolution and sensitivity with industry-leading standardization and ease-of-use features, making the power of advanced flow cytometry more accessible to researchers in academia and pharmaceutical settings, as well as in contract research organization (CRO) labs.
$1000 Invested In Waters 20 Years Ago Would Be Worth This Much Today
Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.59% on an annualized basis producing an average annual return of 11.74%. Currently, Waters has a market capitalization of $39.99 billion. Buying
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference on Wednesday, September 23, 2026, at 12:00 PM BST (GMT+1) / 7:00 AM Eastern Time.
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Analysts upgraded SFNC, OBIO, and more.
Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Waters Corporation (WAT) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 10:15 AM EDTCompany ParticipantsUdit Batra - President, CEO &...
This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and improving ratings.
UBS Upgrades Waters to Buy, Raises Price Target to $490
UBS analyst Doug Schenkel upgrades Waters (NYSE:WAT) from Neutral to Buy and raises the price target from $375 to $490.
Waters (WAT) Stock Could Be A Bargain On Cash Flow Yet Fully Priced On Sales
Waters stock has put in a strong multi year gain, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while the earnings multiple checks lean expensive. Over the past 3 years, Waters has returned about 53%, which puts more pressure on today’s entry price to be well supported by fundamentals. The company’s ability to keep converting its specialized analytical instruments and services into steady cash flow can...
Waters (WAT) Raised Guidance, Is The Stock Still Cheap?
Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted a 30 day share price return of 4.41% and a 90 day share price return of 13.19%. The 1 year total shareholder return of 38% and 3 year total shareholder return of 53% point to building momentum supported by upgraded guidance and recent leadership...
Leadership Shift And Upgraded Outlook Could Be A Game Changer For Waters (WAT)
Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, previously head of the Materials Sciences Division and President, China, stepping into the role after more than two decades of global leadership experience at DuPont. Around the same time, Waters reported very large year-over-year revenue growth in the second quarter of 2026 and raised its full-year guidance, underlining the...
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-06 | KUEBLER CHRISTOPHER A | -3,626 | - | - |
| 2026-08-06 | KUEBLER CHRISTOPHER A | -3,626 | $397.94 | $1,442,930 |
| 2026-08-06 | KUEBLER CHRISTOPHER A | +3,626 | $136.43 | $494,695 |
| 2026-06-30 | Knight Heather | +63 | - | - |
| 2026-06-30 | Jiang Wei | +67 | - | - |
| 2026-06-24 | Carpio Robert L III | -189 | $369.18 | $69,775 |
| 2026-05-12 | Chaubal Amol | -239 | $352.21 | $84,178 |
| 2026-04-06 | Bennett Jianqing | -302 | $304.09 | $91,835 |
| 2026-03-31 | Jiang Wei | +64 | - | - |
| 2026-03-31 | Knight Heather | +68 | - | - |
| 2026-03-16 | Jiang Wei | +500 | $289.46 | $144,730 |
| 2026-03-06 | FEARON RICHARD H | +1,000 | $306.34 | $306,340 |
| 2026-03-02 | Batra Udit | -3,417 | $307.23 | $1,049,805 |
| 2026-03-02 | Chaubal Amol | -709 | $307.23 | $217,826 |
| 2026-03-02 | Bennett Jianqing | -410 | $307.23 | $125,964 |
| 2026-02-25 | Carpio Robert L III | +4,884 | - | - |
| 2026-02-25 | Carpio Robert L III | +997 | - | - |
| 2026-02-25 | Bennett Jianqing | +4,826 | - | - |
| 2026-02-25 | Bennett Jianqing | +986 | - | - |
| 2026-02-25 | Chaubal Amol | +7,125 | - | - |
| 2026-02-25 | Chaubal Amol | +1,455 | - | - |
| 2026-02-25 | Batra Udit | +25,283 | - | - |
| 2026-02-25 | Batra Udit | +5,165 | - | - |
| 2026-02-25 | Vergnano Mark | +57 | - | - |
| 2026-02-25 | Vergnano Mark | +23 | - | - |
| 2026-02-25 | KUEBLER CHRISTOPHER A | +57 | - | - |
| 2026-02-25 | KUEBLER CHRISTOPHER A | +23 | - | - |
| 2026-02-25 | Knight Heather | +57 | - | - |
| 2026-02-25 | Knight Heather | +23 | - | - |
| 2026-02-25 | Jiang Wei | +57 | - | - |
| 2026-02-25 | Jiang Wei | +23 | - | - |
| 2026-02-25 | Huang Pearl S | +57 | - | - |
| 2026-02-25 | Huang Pearl S | +23 | - | - |
| 2026-02-25 | Fraser Claire | +877 | - | - |
| 2026-02-25 | Fraser Claire | +358 | - | - |
| 2026-02-25 | FEARON RICHARD H | +57 | - | - |
| 2026-02-25 | FEARON RICHARD H | +23 | - | - |
| 2026-02-25 | Brennan Daniel J. | +57 | - | - |
| 2026-02-25 | Brennan Daniel J. | +23 | - | - |
| 2026-02-25 | BADDOUR LINDA | +57 | - | - |
| 2026-02-25 | BADDOUR LINDA | +23 | - | - |
| 2026-02-25 | Ornskov Flemming | +57 | - | - |
| 2026-02-25 | Ornskov Flemming | +336 | - | - |
| 2026-02-05 | Carpio Robert L III | -38 | $376.89 | $14,322 |
| 2026-02-05 | Bennett Jianqing | -43 | $376.89 | $16,206 |
| 2026-02-05 | Chaubal Amol | -58 | $376.89 | $21,860 |
| 2026-02-05 | Batra Udit | -218 | $376.89 | $82,162 |
| 2026-02-04 | Bennett Jianqing | +1,385 | - | - |
| 2026-02-04 | Chaubal Amol | +1,884 | - | - |
| 2026-02-04 | Batra Udit | +7,066 | - | - |
| 2026-01-02 | Brennan Daniel J. | +828 | - | - |
| 2026-01-02 | Brennan Daniel J. | +307 | - | - |
| 2026-01-02 | Vergnano Mark | +828 | - | - |
| 2026-01-02 | Vergnano Mark | +307 | - | - |
| 2026-01-02 | KUEBLER CHRISTOPHER A | +828 | - | - |
| 2026-01-02 | KUEBLER CHRISTOPHER A | +307 | - | - |
| 2026-01-02 | Huang Pearl S | +828 | - | - |
| 2026-01-02 | Huang Pearl S | +307 | - | - |
| 2026-01-02 | FEARON RICHARD H | +828 | - | - |
| 2026-01-02 | FEARON RICHARD H | +307 | - | - |
| 2026-01-02 | BADDOUR LINDA | +828 | - | - |
| 2026-01-02 | BADDOUR LINDA | +307 | - | - |
| 2026-01-02 | Ornskov Flemming | +828 | - | - |
| 2026-01-02 | Ornskov Flemming | +307 | - | - |
| 2026-01-02 | Jiang Wei | +828 | - | - |
| 2026-01-02 | Jiang Wei | +307 | - | - |
| 2026-01-02 | Knight Heather | +828 | - | - |
| 2026-01-02 | Knight Heather | +307 | - | - |
| 2025-12-31 | Jiang Wei | +60 | - | - |
| 2025-12-31 | Knight Heather | +60 | - | - |
| 2025-11-05 | KUEBLER CHRISTOPHER A | -3,761 | - | - |
| 2025-11-05 | KUEBLER CHRISTOPHER A | -1,318 | $371.97 | $490,256 |
| 2025-11-05 | KUEBLER CHRISTOPHER A | +3,761 | $130.35 | $490,246 |